These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31104397)

  • 1. BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression.
    Narimani M; Sharifi M; Hakhamaneshi MS; Roshani D; Kazemi M; Hejazi SH; Jalili A
    Iran Biomed J; 2019 Nov; 23(6):369-78. PubMed ID: 31104397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockout Of
    Narimani M; Sharifi M; Jalili A
    Blood Lymphat Cancer; 2019; 9():53-61. PubMed ID: 31819702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
    Moore AS; Alonzo TA; Gerbing RB; Lange BJ; Heerema NA; Franklin J; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S
    Pediatr Blood Cancer; 2014 Apr; 61(4):647-52. PubMed ID: 24127439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.
    Zha J; Lai Q; Deng M; Shi P; Zhao H; Chen Q; Wu H; Xu B
    Stem Cell Rev Rep; 2020 Dec; 16(6):1280-1291. PubMed ID: 33057942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
    Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
    Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
    Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.
    Baradaran B; Nazmabadi R; Ariyan Z; Sakhinia E; Karami H
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2523-2530. PubMed ID: 35901361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.
    Pise-Masison CA; Radonovich M; Dohoney K; Morris JC; O'Mahony D; Lee MJ; Trepel J; Waldmann TA; Janik JE; Brady JN
    Blood; 2009 Apr; 113(17):4016-26. PubMed ID: 19131553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.
    Huang Z; Nair M
    Sci Rep; 2017 Jul; 7(1):5955. PubMed ID: 28729655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-100 regulates cell viability and apoptosis by targeting ATM in pediatric acute myeloid leukemia.
    Sun Y; Wang H; Luo C
    Biochem Biophys Res Commun; 2020 Feb; 522(4):855-861. PubMed ID: 31801665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
    Chuwa AH; Sone K; Oda K; Ikeda Y; Fukuda T; Wada-Hiraike O; Inaba K; Makii C; Takeuchi M; Oki S; Miyasaka A; Kashiyama T; Arimoto T; Kuramoto H; Kawana K; Yano T; Osuga Y; Fujii T
    Gynecol Oncol; 2016 Jun; 141(3):564-569. PubMed ID: 27079211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer.
    Santa-Inez DC; Fuziwara CS; Saito KC; Kimura ET
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.
    Zhao G; Wang Q; Gu Q; Qiang W; Wei JJ; Dong P; Watari H; Li W; Yue J
    Oncotarget; 2017 Nov; 8(55):94666-94680. PubMed ID: 29212257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
    Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells.
    Liu X; Zhang Y; Cheng C; Cheng AW; Zhang X; Li N; Xia C; Wei X; Liu X; Wang H
    Cell Res; 2017 Jan; 27(1):154-157. PubMed ID: 27910851
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.